Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020685

Expand all

CRIXIVAN (INDINAVIR SULFATE)
EQ 100MG BASE
Marketing Status: Discontinued

Active Ingredient: INDINAVIR SULFATE
Proprietary Name: CRIXIVAN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020685
Product Number: 006
Approval Date: Apr 19, 2000
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

CRIXIVAN (INDINAVIR SULFATE)
EQ 200MG BASE
Marketing Status: Discontinued

Active Ingredient: INDINAVIR SULFATE
Proprietary Name: CRIXIVAN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 200MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020685
Product Number: 003
Approval Date: Mar 13, 1996
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

CRIXIVAN (INDINAVIR SULFATE)
EQ 333MG BASE
Marketing Status: Discontinued

Active Ingredient: INDINAVIR SULFATE
Proprietary Name: CRIXIVAN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 333MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020685
Product Number: 005
Approval Date: Dec 17, 1998
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

CRIXIVAN (INDINAVIR SULFATE)
EQ 400MG BASE
Marketing Status: Discontinued

Active Ingredient: INDINAVIR SULFATE
Proprietary Name: CRIXIVAN
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 400MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020685
Product Number: 001
Approval Date: Mar 13, 1996
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information